The price of this share is at 0,61$, Monopar Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Andrew P. Mazar (Director & Chief Scientific Officer), Chandler Drew Robinson (President, Chief Executive Officer & Director), Kim R. Tsuchimoto (Chief Financial Officer, Secretary & Treasurer), Laura Kelly (Director-Clinical Operations), Octßvio Costa (Chief Medical Officer) and its address is 1000 SKOKIE BOULEVARD SUITE 350, WILMETTE, Illinois, 60091, United States.
Yesterday this stock ended the day with a value of desconocido$.
The current range on the same day is from 0,60$ - 0,63$, with a percentage difference of 0,62$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
